BACKGROUND: Systematic work-up of patients with myocardial infarction and non-obstructive coronary artery disease (MINOCA) using cardiac magnetic resonance imaging (CMR) led to a more than six-fold increase in the detection rate of myocarditis. In this study, we expanded on our prior two-year analysis by including preceding and subsequent years.
Systematic use of cardiac magnetic resonance imaging in MINOCA led to a five-fold increase in the detection rate of myocarditis: a retrospective study Summary BACKGROUND: Systematic work-up of patients with myocardial infarction and non-obstructive coronary artery disease (MINOCA) using cardiac magnetic resonance imaging (CMR) led to a more than six-fold increase in the detection rate of myocarditis. In this study, we expanded on our prior two-year analysis by including preceding and subsequent years.
METHODS: We performed a retrospective chart review of patients with angina-like symptoms and elevated highsensitivity troponin T (TnT-hs ≥14 ng/l) but without significant coronary artery disease, from 2011 to 2017. Patients underwent CMR to test for myocarditis. From 2011 to 2015, only patients with elevated TnT-hs, no significant coronary artery disease and moderate to high clinical likelihood of suffering from myocarditis, underwent CMR. In 2016 and 2017, CMR images were obtained from all patients with MINOCA, independent of the clinical likelihood that patients were suffering from myocarditis.
RESULTS: A total of 556 patients who underwent CMR (70.5% male, 57 ± 17 years, with an average left ventricular ejection fraction of 51 ± 15%) qualified for inclusion in this study's analysis. From 2011 to 2015, 240 CMR examinations were performed, with the number increasing to 316 between 2016 and 2017. In total, myocarditis was diagnosed in 76 out of the 556 patients (13.7%). Between
Introduction
Myocarditis is a heterogeneous inflammatory heart disease which manifests itself through a variety of symptoms [1, 2] . Over time, its clinical development can take an adverse trajectory and result in dilated cardiomyopathy (DCM), impaired left ventricular ejection fraction (LVEF) [3] , malignant arrhythmias and sudden cardiac death (SCD) [2, [4] [5] [6] . Even though endomyocardial biopsy and cardiac magnetic resonance imaging (CMR) are increasingly used to diagnose myocarditis [2, 7, 8] , the true incidence of myocarditis remains unknown [9] . Post mortem studies have identified myocarditis in up to 42% [5, 10] of cases of SCD, suggesting a significant epidemiological impact. Hence, a systematic change of the diagnostic algorithm may be necessary to improve the rate of myocarditis detection in patients [11] .
As symptoms of myocarditis can mimic myocardial infarction and lead to elevated troponin levels [2] [12], inflammatory cardiomyopathy is commonly found amongst patients with angina-like symptoms, elevated high-sensitivity troponin-T (TnT-hs) and unobstructed coronaries (i.e. myocardial infarction and non-obstructive coronary artery disease [MINOCA]) [13] [14] [15] . This clinically challenging population often does not receive specific treatment [16, 17] and was found to display an increased mortality rate [18] . In patients with MINOCA, multiple underlying mechanisms have been suspected to be the cause of the disease, including coronary spasm, coronary microvascular dysfunction, myocarditis, Takotsubo syndrome (TTS), spontaneous coronary thrombosis and emboli [18] . Interestingly, myocarditis is one of the most common underlying causes within this patient population, with the percentage of cases ranging from 16 to 50% [19, 20] .
While endomyocardial biopsy (EMB) remains the gold standard [21] for the diagnosis of myocarditis, CMR has been established as a non-invasive alternative for the diagnosis of myocarditis, when EMB is not indicated [14, 22] . In a previous pilot study, we showed that the introduction of a novel diagnostic algorithm using a lowered threshold for CMR led to a 6.3-fold increase of the incidence of myocarditis in patients with MINOCA. Furthermore, the algorithm increased the percentage of CMRs that tested positive for myocarditis [23] . In order to confirm these first results, we expanded our analysis to the preceding and subsequent years, thereby evaluating a potential temporary incidence peak in 2016. We hypothesised that the detection rate of myocarditis would continue to be higher in 2017, when CMR was systematically applied, compared to the detection rate between 2011 and 2015, when CMR was performed only when there had been moderate to high clinical suspicion of myocarditis.
Methods

Study design
This was a retrospective single-centre study investigating a new diagnostic algorithm for myocarditis amongst patients with MINOCA. The study was performed at the University Hospital of Zurich, a tertiary health care centre with 980 hospital beds, covering the catchment area of the Canton of Zurich with approximately 1.5 million citizens. The cohort includes patients who were admitted to the University Hospital Zurich between January 2011 and December 2017 with angina-like symptoms, elevated levels of TnT-hs (reference range 0-14 ng/l) and non-obstructive coronary artery disease (CAD) (<50% stenosis) and who underwent CMR for further diagnostic work-up. CAD was excluded using coronary angiography by cardiac catheterization or computed tomography (CT) and CMR if pretest probability of CAD was very low [23] . No patients were excluded. CMR analyses were performed under the supervision of the head of cardiac imaging who performed CMR between early 2011 and late 2018 and who had more than eleven years of experience in CMR.
In the years 2011 to 2015, only patients with classical symptoms of myocarditis, such as chest pain, dyspnoea and palpitations after viral prodrome, underwent CMR. Starting in 2016, the threshold for CMR imaging was lowered to examine all unexplained cases of MINOCA in line with current guidelines [24] . A MRI was performed within 90 days after symptom onset.
Outcome measurements
The primary goal of this study was to measure the detection rate of myocarditis amongst patients suffering from MINOCA, using systematic CMR work-up at our institution, the University Hospital Zurich, before and after implementation of a new diagnostic work-up algorithm. To evaluate the impact of this use of CMR, we compared the number of detected cases of myocarditis after its introduction in 2016 and 2017 with the preceding five years, from 2011 to 2015.
In addition, we compared baseline characteristics of patients with MINOCA without signs for myocarditis, with the characteristics of patients suffering from myocarditis. We described the presence of other types of cardiomyopathies identified by CMR amongst patients with MINOCA at the University Hospital Zurich between 2011 and 2017. Finally, we evaluated potential differences in our baseline characteristics between patients with myocarditis and MINOCA in order to evaluate potential clinical differences.
Clinical database
Clinical data were generated with the help of the University Hospital Zurich's electronic medical records database. All patients were anonymised and numbered sequentially. IBM SPSS Statistics version 22 and MedCalc version 18.5 were used to carry out calculations and analysis. The study was approved by the Ethics Committee of Zurich (PB_2016_01152).
CMR examination
CMR images were generated using a 1.5 or 3.0 Tesla scanner (SiemensSkyra, Erlangen, Germany or Phillips Achieva Best, Netherlands) with electrocardiography-gated breath-hold protocol and weight-adapted dose of gadolinium-based contrast agent (Gadovist, Bayer AG, Zurich, Switzerland) (0.1 mmol/kg). Diagnosis of myocarditis was based on cine-CMR, T2-weighted imaging and Late Gadolinium Enhancement (LGE) images [25] [26] [27] . Edema was assessed using T2-weighted images. Images were obtained using a surface coil [25] [26] [27] .
LGE images were acquired 10 minutes after an intravenous injection of a gadolinium-based contrast agent and were used to detect necrosis.
LGE was categorised according to its localisation, distribution and pattern using the 17 segment model. Epicardial or midwall distribution of LGE, associated with a patchy pattern and non-coronary distribution, were regarded as potential indicators for myocarditis.
Statistical analysis
Descriptive statistics were used to examine clinical data. Metric scale parameters were described as averages accompanied by their standard deviation. Nominal scale parameters were reported as total numbers and as percentages of the total number of patients who underwent CMR in a particular year. Diagnoses of rare diseases, such as scleroderma, pericardial effusion and coronary anomalies, were summarised as "others". Baseline characteristics of patients with myocarditis vs. normal CMR findings were compared using Student's t-test and chi-square test for equality of proportions. A p-value <0.05 was considered significant for all statistical tests.
In order to compare the detection rate for myocarditis by CMR in 2016 and 2017 with that between 2011 and 2015, percentages of positive CMR findings for myocarditis for each time interval were compared using the chi-square test.
Detection rate among the total number of patients who underwent CMR at the University Hospital of Zurich was calculated. The detection ratio compares the total rate between 2011 and 2015 to that between 2016 and 2017. Normal heart, n (%) 18 (51. 
Results
Baseline characteristics
Amyloidosis, n (%) 1 (2.9) 0 (0) 0 (0) 1 (1.6) 1 (1.1) 2 (1) 3 (2.6) 8 (1.4) Sarcoidosis, n (%) 1 (2.9) 0 (0) 0 (0) 0 (0) 1 (1.1) 1 (0.5) 2 (1.7) 5 (0.9) FD, n (%) 0 (0) 1 (3.7) 0 (0) 0 (0) 1 (1.1) 1 (0.5) 0 (0) 3 (0.5) TTS, n (%) 0 (0) 0 (0) 1 (3.6) 0 (0) 0 (0) 4(
Myocarditis vs MINOCA
We identified 76 cases of myocarditis between 2011 and 2017. Patients suffering from myocarditis were significantly younger (47 ± 17 years vs 58 ± 17; p = 0.00000075) and more likely to be male (81.6 vs 68.8%; p = 0.023) than MINOCA patients, in whom no CMR signs of myocarditis could be detected. Average LVEF on CMR was 51 ± 14% and did not differ between the two groups.
Discussion
During the course of this study, we found a remarkable increase in the detection rate of myocarditis at the University Hospital Zurich over two subsequent years as a result of the implementation of a systematic CMR work-up algorithm for patients suffering from MINOCA.
We recently reported the detection rate of myocarditis in 2015 vs 2016 at the University Hospital Zurich following the implementation of a novel diagnostic work-up algorithm in January 2016 in a pilot study, in which patients with MINOCA were given a systematic work-up through CMR [23] . We were able to detect a 6.3-fold increase in the approximated incidence of myocarditis. Following the success of this algorithm, it was decided to continue with it in 2017. Through this new, additional study we were able to verify our earlier results over a longer time period. We compared the number of cases of myocarditis diagnosed by CMR in patients suffering from MINOCA in 2016-2017, with the number of identified cases of myocarditis in the previous years, 2011-2015, in which the threshold for performing CMR in patients with MINOCA was higher. The finding of a 4.9-fold increase in the total detection rate of myocarditis between 2016 and 2017 based on CMR and clinical findings compared to previous years, suggests that myocarditis continues to be underdetected. This supports the notion that diagnostic work-up tools have to be improved [1, 5, 14, 15, 20, 23, 28, 29] . Nonetheless, the ex- Similarly to previous studies, we found myocarditis to be the most common underlying cause in patients who suffer from MINOCA and who undergo CMR [14, 15, 18, 23] . Interestingly, the percentage of CMR scans which tested positive for myocarditis (22.2% in 2017) was lower than previously described in literature. For instance, Pasupathy et al. found myocarditis to be present in 33% of CMRs in MINOCA patients based on 26 publications [18] . Moreover, studies on the diagnostic yield of CMR in MINOCA showed myocarditis to be present in 41.6-59.9% [14, 15] . In addition, they revealed a considerably lower rate of unremarkable CMR scans with only 8-10.3% [14, 15] compared to the rates we found in our study (in total, 59.7%). However, we did include all CMR scans with a clinical suspicion of myocarditis, while the afore-mentioned studies excluded patients suffering from known cardiac diseases. This could have led to higher concentrations of relevant findings in the other publications.
Consistent with previous studies, patients with myocarditis were significantly younger and more frequently male than those who were not diagnosed with myocarditis [14, 31] . LVEF did not vary between cases of myocarditis and nonmyocarditis with a globally just mildly impaired LVEF (51 ± 15%). Other underlying cause diagnoses in CMR, with the exception of DCM, did not differ between the periods of time 2011-2015 and 2016-2017.
In summary, systematic work-up of patients with MINOCA implemented in 2016 led to an almost five-fold increase in the diagnosis of myocarditis for two consecutive years compared to the preceding five years. While the lack of tissue diagnosis is a limitation of this study, wide diagnostic work-up with low risk of complications can only be applied through a non-invasive approach. Thus, this non-invasive approach provides an approximation of the true incidence of myocarditis.
Due to the retrospective character of the study, as well as the single centre design, the global applicability of our results is limited. As mentioned above, a limitation of this study was that histopathological confirmation of my-ocarditis was not performed because we followed the guidelines for endomyocardial biopsy, which restrict the indication for endomyocardial biopsy as a more severe clinical course [25] . Moreover, CMR diagnosis was performed within three months of, rather than immediately upon, symptom onset. This may have affected CMR findings, since edema and LGE are dynamic and, in general, regress during the clinical course. Furthermore, we did not use the most recent T1 and T2 mapping techniques, which could have led to a higher detection rate of myocarditis on CMR [32] .
Conclusion
The successful identification of the underlying illness of patients with MINOCA may be challenging without additional diagnostic imaging. We have demonstrated that systematic work-up of patients with angina-like symptoms, elevated troponin and no significant coronary artery disease, lea to an almost five-fold increase in the diagnosis of myocarditis in our tertiary care centre. These data suggest that myocarditis remains underdiagnosed and that lowering the threshold for diagnostic work-up with CMR may help to identify myocarditis early. Timely and accurate diagnosis is crutial as certain subtypes of myocarditis require specific therapy. Furthermore, following diagnosis of myocarditis, strenuous activity should be avoided for three to six weeks, since the risk of exercise-induced arrhythmias may be higher during that period.
